1. Home
  2. NTRB vs BNTC Comparison

NTRB vs BNTC Comparison

Compare NTRB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRB
  • BNTC
  • Stock Information
  • Founded
  • NTRB 2016
  • BNTC 1995
  • Country
  • NTRB United States
  • BNTC United States
  • Employees
  • NTRB N/A
  • BNTC N/A
  • Industry
  • NTRB Industrial Specialties
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTRB Health Care
  • BNTC Health Care
  • Exchange
  • NTRB Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • NTRB 77.9M
  • BNTC 88.1M
  • IPO Year
  • NTRB N/A
  • BNTC N/A
  • Fundamental
  • Price
  • NTRB $6.17
  • BNTC $10.65
  • Analyst Decision
  • NTRB
  • BNTC Strong Buy
  • Analyst Count
  • NTRB 0
  • BNTC 5
  • Target Price
  • NTRB N/A
  • BNTC $22.60
  • AVG Volume (30 Days)
  • NTRB 28.2K
  • BNTC 39.8K
  • Earning Date
  • NTRB 12-11-2024
  • BNTC 11-11-2024
  • Dividend Yield
  • NTRB N/A
  • BNTC N/A
  • EPS Growth
  • NTRB N/A
  • BNTC N/A
  • EPS
  • NTRB N/A
  • BNTC N/A
  • Revenue
  • NTRB $1,803,816.00
  • BNTC N/A
  • Revenue This Year
  • NTRB N/A
  • BNTC N/A
  • Revenue Next Year
  • NTRB N/A
  • BNTC N/A
  • P/E Ratio
  • NTRB N/A
  • BNTC N/A
  • Revenue Growth
  • NTRB N/A
  • BNTC N/A
  • 52 Week Low
  • NTRB $1.93
  • BNTC $2.69
  • 52 Week High
  • NTRB $9.60
  • BNTC $12.89
  • Technical
  • Relative Strength Index (RSI)
  • NTRB 50.57
  • BNTC 55.32
  • Support Level
  • NTRB $5.24
  • BNTC $10.70
  • Resistance Level
  • NTRB $6.40
  • BNTC $11.05
  • Average True Range (ATR)
  • NTRB 0.71
  • BNTC 0.74
  • MACD
  • NTRB -0.12
  • BNTC -0.02
  • Stochastic Oscillator
  • NTRB 33.23
  • BNTC 50.94

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Share on Social Networks: